Daniel Jahn1, Donata Dorbath1, Anne-Kristin Schilling1, Lisa Gildein1, Chantal Meier2, Raphael N Vuille-Dit-Bille2, Johannes Schmitt1, Daniel Kraus3, James C Fleet4, Heike M Hermanns1, Andreas Geier5. 1. University Hospital Würzburg, Division of Hepatology, Würzburg, Germany. 2. University of Zürich, Institute of Physiology, Zürich, Switzerland. 3. University Hospital Würzburg, Division of Nephrology, Würzburg, Germany. 4. Purdue University, Department of Nutrition Science, West Lafayette, IN, USA. 5. University Hospital Würzburg, Division of Hepatology, Würzburg, Germany; University Hospital Zürich, Division of Gastroenterology and Hepatology, Zürich, Switzerland. Electronic address: Geier_A2@ukw.de.
Abstract
OBJECTIVE: Hypovitaminosis D is common in the obese population and patients suffering from obesity-associated disorders such as type 2 diabetes and fatty liver disease, resulting in suggestions for vitamin D supplementation as a potential therapeutic option. However, the pathomechanistic contribution of the vitamin D-vitamin D receptor (VDR) axis to metabolic disorders is largely unknown. METHODS: We analyzed the pathophysiological role of global and intestinal VDR signaling in diet-induced obesity (DIO) using global Vdr-/- mice and mice re-expressing an intestine-specific human VDR transgene in the Vdr deficient background (Vdr-/- hTg). RESULTS: Vdr-/- mice were protected from DIO, hepatosteatosis and metabolic inflammation in adipose tissue and liver. Furthermore, Vdr-/- mice displayed a decreased adipose tissue lipoprotein lipase (LPL) activity and a reduced capacity to harvest triglycerides from the circulation. Intriguingly, all these phenotypes were partially reversed in Vdr-/- hTg animals. This clearly suggested an intestine-based VDR activity on systemic lipid homeostasis. Scrutinizing this hypothesis, we identified the potent LPL inhibitor angiopoietin-like 4 (Angptl4) as a novel transcriptional target of VDR. CONCLUSION: Our study suggests a VDR-mediated metabolic cross-talk between gut and adipose tissue, which significantly contributes to systemic lipid homeostasis. These results have important implications for use of the intestinal VDR as a therapeutic target for obesity and associated disorders.
OBJECTIVE: Hypovitaminosis D is common in the obese population and patients suffering from obesity-associated disorders such as type 2 diabetes and fatty liver disease, resulting in suggestions for vitamin D supplementation as a potential therapeutic option. However, the pathomechanistic contribution of the vitamin D-vitamin D receptor (VDR) axis to metabolic disorders is largely unknown. METHODS: We analyzed the pathophysiological role of global and intestinal VDR signaling in diet-induced obesity (DIO) using global Vdr-/- mice and mice re-expressing an intestine-specific humanVDR transgene in the Vdr deficient background (Vdr-/- hTg). RESULTS:Vdr-/- mice were protected from DIO, hepatosteatosis and metabolic inflammation in adipose tissue and liver. Furthermore, Vdr-/- mice displayed a decreased adipose tissue lipoprotein lipase (LPL) activity and a reduced capacity to harvest triglycerides from the circulation. Intriguingly, all these phenotypes were partially reversed in Vdr-/- hTg animals. This clearly suggested an intestine-based VDR activity on systemic lipid homeostasis. Scrutinizing this hypothesis, we identified the potent LPL inhibitor angiopoietin-like 4 (Angptl4) as a novel transcriptional target of VDR. CONCLUSION: Our study suggests a VDR-mediated metabolic cross-talk between gut and adipose tissue, which significantly contributes to systemic lipid homeostasis. These results have important implications for use of the intestinal VDR as a therapeutic target for obesity and associated disorders.
Authors: Ahmed Ghallab; Maiju Myllys; Adrian Friebel; Julia Duda; Karolina Edlund; Emina Halilbasic; Mihael Vucur; Zaynab Hobloss; Lisa Brackhagen; Brigitte Begher-Tibbe; Reham Hassan; Michael Burke; Erhan Genc; Lynn Johann Frohwein; Ute Hofmann; Christian H Holland; Daniela González; Magdalena Keller; Abdel-Latif Seddek; Tahany Abbas; Elsayed S I Mohammed; Andreas Teufel; Timo Itzel; Sarah Metzler; Rosemarie Marchan; Cristina Cadenas; Carsten Watzl; Michael A Nitsche; Franziska Kappenberg; Tom Luedde; Thomas Longerich; Jörg Rahnenführer; Stefan Hoehme; Michael Trauner; Jan G Hengstler Journal: Cells Date: 2021-09-23 Impact factor: 6.600
Authors: Anna Andrea Lauer; Lea Victoria Griebsch; Sabrina Melanie Pilz; Daniel Janitschke; Elena Leoni Theiss; Jörg Reichrath; Christian Herr; Christoph Beisswenger; Robert Bals; Teresa Giovanna Valencak; Dorothea Portius; Heike Sabine Grimm; Tobias Hartmann; Marcus Otto Walter Grimm Journal: Biomolecules Date: 2021-11-15